Suraj Kalia's Stock Ratings

Oppenheimer Analyst

Suraj Kalia is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 11/24/2024

Overall Average Return

0.10%

Smart Score

51.4%

Overall Average Return Percentile

35th

Number of Ratings

111
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Navigating 11 Analyst Ratings For TransMedics Gr
Where Artivion Stands With Analysts
Analyst Ratings For Abbott Laboratories
Beyond The Numbers: 13 Analysts Discuss TransMedics Gr Stock
Cracking The Code: Understanding Analyst Reviews For Edwards Lifesciences
Assessing Artivion: Insights From 6 Financial Analysts
The Latest Analyst Ratings For Artivion
Beyond The Numbers: 9 Analysts Discuss Abbott Laboratories Stock
Beyond The Numbers: 9 Analysts Discuss iRhythm Technologies Stock
Abbott Laboratories Analyst Is Bullish About MedTech, Non-MedTech Growth
Abbott Laboratories' MedTech portfolio currently contributes around 45% of total sales of about $42 billion.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved